Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
British Journal of Hospital Medicine (London, England : 2005)
|
May 8, 2010
Lymphoma in the immunocompromised
Ailsa Sita-Lumsden, Philippa Harris, Mark Bower
Biomarkers in Medicine
|
November 26, 2013
Circulating nucleic acids as biomarkers of prostate cancer
Ailsa Sita-Lumsden, Claire E Fletcher, D Alwyn Dart, et al.
Human Molecular Genetics
|
April 17, 2012
Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer
Claire E Fletcher, D Alwyn Dart, Ailsa Sita-Lumsden, et al.
AIDS (London, England)
|
April 20, 2010
No evidence for a polyomavirus association or aetiology in AIDS-associated nonsmall cell lung cancer
Justin Stebbing, Colin Wickenden, Leandro Castellano, et al.
Analytical Chemistry
|
August 9, 2016
Amplification-Free Detection of Circulating microRNA Biomarkers from Body Fluids Based on Fluorogenic Oligonucleotide-Templated Reaction between Engineered Peptide Nucleic Acid Probes: Application to Prostate Cancer Diagnosis
Gavin A D Metcalf, Akifumi Shibakawa, Hinesh Patel, et al.
Future Oncology (London, England)
|
September 29, 2022
Long-term effects of COVID-19 on cancer patients: the experience from Guy's Cancer Centre
Maria J Monroy-Iglesias, Kathryn Tremble, Beth Russell, et al.
British Journal of Cancer
|
August 22, 2022
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
Alessio Cortellini, Juan Aguilar-Company, Ramon Salazar, et al.
Breast Cancer Research and Treatment
|
January 19, 2019
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience
Nicolò Matteo Luca Battisti, Belinda Kingston, Judy King, et al.
Cancers
|
June 2, 2021
COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients
Beth Russell, Charlotte L Moss, Kieran Palmer, et al.
Frontiers in Oncology
|
September 9, 2020
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London
Beth Russell, Charlotte Moss, Sophie Papa, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
British Journal of Hospital Medicine (London, England : 2005)
|
May 8, 2010
Lymphoma in the immunocompromised
Ailsa Sita-Lumsden, Philippa Harris, Mark Bower
Biomarkers in Medicine
|
November 26, 2013
Circulating nucleic acids as biomarkers of prostate cancer
Ailsa Sita-Lumsden, Claire E Fletcher, D Alwyn Dart, et al.
Human Molecular Genetics
|
April 17, 2012
Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer
Claire E Fletcher, D Alwyn Dart, Ailsa Sita-Lumsden, et al.
AIDS (London, England)
|
April 20, 2010
No evidence for a polyomavirus association or aetiology in AIDS-associated nonsmall cell lung cancer
Justin Stebbing, Colin Wickenden, Leandro Castellano, et al.
Analytical Chemistry
|
August 9, 2016
Amplification-Free Detection of Circulating microRNA Biomarkers from Body Fluids Based on Fluorogenic Oligonucleotide-Templated Reaction between Engineered Peptide Nucleic Acid Probes: Application to Prostate Cancer Diagnosis
Gavin A D Metcalf, Akifumi Shibakawa, Hinesh Patel, et al.
Future Oncology (London, England)
|
September 29, 2022
Long-term effects of COVID-19 on cancer patients: the experience from Guy's Cancer Centre
Maria J Monroy-Iglesias, Kathryn Tremble, Beth Russell, et al.
British Journal of Cancer
|
August 22, 2022
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
Alessio Cortellini, Juan Aguilar-Company, Ramon Salazar, et al.
Breast Cancer Research and Treatment
|
January 19, 2019
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience
Nicolò Matteo Luca Battisti, Belinda Kingston, Judy King, et al.
Cancers
|
June 2, 2021
COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients
Beth Russell, Charlotte L Moss, Kieran Palmer, et al.
Frontiers in Oncology
|
September 9, 2020
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London
Beth Russell, Charlotte Moss, Sophie Papa, et al.
Page
of 3